| Thomas W Hegland, OD | |
|
407 Avenue K Se, Winter Haven, FL 33880-4126 | |
| (863) 294-3504 | |
| (866) 522-3607 |
| Full Name | Thomas W Hegland |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 39 Years |
| Location | 407 Avenue K Se, Winter Haven, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093733735 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | OPC2053 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Eye Specialists Of Mid Florida Pa | 8022003235 | 19 |
News Archive
Aethon, Inc., the leading developer of mobile robotics for hospital supply chain logistics, is pleased to announce a partnership with the Bosch Group that includes an investment of $5 million through its venture arm, Robert Bosch Venture Capital GmbH.
Spain will held the 16th World Senologyc Congress between the 20th and 22nd of October. This meeting will allow doctors to evaluate the progress achieved in medical and surgical breast cancer treatment and its future challenges. The best time to rebuilding breasts, how to preserve patients' fertility, the use of nodes self-transplant to treat lymphedema, the develop of new molecular targets and the use of stem cells will be some of the key issues to be treated during the congress.
Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic, according to the largest ketamine clinical trial to-date led by researchers from the Icahn School of Medicine at Mount Sinai.
COVID-19 vaccines were designed to reduce the likelihood that infection by the SARS-CoV-2 virus would lead to severe outcomes, such as hospitalization and death. In that sense, all of the currently approved vaccines - Moderna, Pfizer and Johnson & Johnson - have proven comparably effective.
With employers and individuals continuing to struggle with rising health care costs, a new study shows there is one strategy that is proven to slow the pace of this ever increasing burden: preventive health. Published today in Population Health Management, "The Impact of The Prevention Plan on Employee Health Risk Reduction" reveals that prevention programs based on the clinical practice of preventive medicine are able to achieve measurable health risk reduction in just one year.
› Verified 2 days ago
| Provider Name | Eye Specialists Of Mid Florida Pa |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1366437162 PECOS PAC ID: 8022003235 Enrollment ID: O20040417000072 |
News Archive
Aethon, Inc., the leading developer of mobile robotics for hospital supply chain logistics, is pleased to announce a partnership with the Bosch Group that includes an investment of $5 million through its venture arm, Robert Bosch Venture Capital GmbH.
Spain will held the 16th World Senologyc Congress between the 20th and 22nd of October. This meeting will allow doctors to evaluate the progress achieved in medical and surgical breast cancer treatment and its future challenges. The best time to rebuilding breasts, how to preserve patients' fertility, the use of nodes self-transplant to treat lymphedema, the develop of new molecular targets and the use of stem cells will be some of the key issues to be treated during the congress.
Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic, according to the largest ketamine clinical trial to-date led by researchers from the Icahn School of Medicine at Mount Sinai.
COVID-19 vaccines were designed to reduce the likelihood that infection by the SARS-CoV-2 virus would lead to severe outcomes, such as hospitalization and death. In that sense, all of the currently approved vaccines - Moderna, Pfizer and Johnson & Johnson - have proven comparably effective.
With employers and individuals continuing to struggle with rising health care costs, a new study shows there is one strategy that is proven to slow the pace of this ever increasing burden: preventive health. Published today in Population Health Management, "The Impact of The Prevention Plan on Employee Health Risk Reduction" reveals that prevention programs based on the clinical practice of preventive medicine are able to achieve measurable health risk reduction in just one year.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thomas W Hegland, OD 407 Avenue K Se, Winter Haven, FL 33880-4126 Ph: (863) 294-3504 | Thomas W Hegland, OD 407 Avenue K Se, Winter Haven, FL 33880-4126 Ph: (863) 294-3504 |
News Archive
Aethon, Inc., the leading developer of mobile robotics for hospital supply chain logistics, is pleased to announce a partnership with the Bosch Group that includes an investment of $5 million through its venture arm, Robert Bosch Venture Capital GmbH.
Spain will held the 16th World Senologyc Congress between the 20th and 22nd of October. This meeting will allow doctors to evaluate the progress achieved in medical and surgical breast cancer treatment and its future challenges. The best time to rebuilding breasts, how to preserve patients' fertility, the use of nodes self-transplant to treat lymphedema, the develop of new molecular targets and the use of stem cells will be some of the key issues to be treated during the congress.
Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic, according to the largest ketamine clinical trial to-date led by researchers from the Icahn School of Medicine at Mount Sinai.
COVID-19 vaccines were designed to reduce the likelihood that infection by the SARS-CoV-2 virus would lead to severe outcomes, such as hospitalization and death. In that sense, all of the currently approved vaccines - Moderna, Pfizer and Johnson & Johnson - have proven comparably effective.
With employers and individuals continuing to struggle with rising health care costs, a new study shows there is one strategy that is proven to slow the pace of this ever increasing burden: preventive health. Published today in Population Health Management, "The Impact of The Prevention Plan on Employee Health Risk Reduction" reveals that prevention programs based on the clinical practice of preventive medicine are able to achieve measurable health risk reduction in just one year.
› Verified 2 days ago
Edward Attaway, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 407 Avenue K Se, Winter Haven, FL 33880 Phone: 863-294-3504 Fax: 863-294-8305 | |
Dr. John Tivnan, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 407 Avenue K Se, Winter Haven, FL 33880 Phone: 863-294-3504 Fax: 863-299-0096 | |
Sonya Braudway, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 250 Avenue K Sw, Suite 200, Winter Haven, FL 33880 Phone: 863-297-5400 Fax: 863-293-8230 | |
Dr. Thomas Brinton, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 407 Avenue K Se, Winter Haven, FL 33880 Phone: 863-294-3504 Fax: 863-294-8305 | |
Katie M Salomon, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 570 Avenue K Se, Winter Haven, FL 33880 Phone: 863-401-4200 Fax: 863-220-9912 | |
Dr. John Linden Davidson, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 407 Avenue K Se, Winter Haven, FL 33880 Phone: 863-294-3504 Fax: 863-294-8305 |